{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:45:58Z","timestamp":1783662358894,"version":"3.55.0"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/11(13)\/2019"],"award-info":[{"award-number":["ISRM\/11(13)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11262-022-01898-5","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T06:10:56Z","timestamp":1649398256000},"page":"151-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-1257","authenticated-orcid":false,"given":"Shobana","family":"Sundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmughavel","family":"Piramanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyakumar","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"issue":"1","key":"1898_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cbpa.2008.01.045","volume":"12","author":"J Weigelt","year":"2008","unstructured":"Weigelt J, McBroom-Cerajewski LD, Schapira M, Zhao Y, Arrowmsmith CH (2008) Structural genomics and drug discovery: all in the family. Curr Opin Chem Biol 12(1):32\u201339","journal-title":"Curr Opin Chem Biol"},{"issue":"5540","key":"1898_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1066011","volume":"294","author":"RC Stevens","year":"2001","unstructured":"Stevens RC, Yokoyama S, Wilson IA (2001) Global efforts in structural genomics. Science 294(5540):89\u201392","journal-title":"Science"},{"issue":"22","key":"1898_CR3","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00018-006-6252-y","volume":"63","author":"K Lundstrom","year":"2006","unstructured":"Lundstrom K (2006) Structural genomics for membrane proteins. Cell Mol Life Sci 63(22):2597\u20132607","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1898_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tibtech.2004.12.006","volume":"23","author":"K Lundstrom","year":"2005","unstructured":"Lundstrom K (2005) Structural genomics of GPCRs. Trends Biotechnol 23(2):103\u2013108","journal-title":"Trends Biotechnol"},{"issue":"1","key":"1898_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cbpa.2008.01.042","volume":"12","author":"BD Marsden","year":"2008","unstructured":"Marsden BD, Knapp S (2008) Doing more than just the structure\u2014structural genomics in kinase drug discovery. Curr Opin Chem Biol 12(1):40\u201345","journal-title":"Curr Opin Chem Biol"},{"key":"1898_CR6","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/vector-borne-diseases"},{"key":"1898_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01964","author":"PM Zanotto","year":"2018","unstructured":"Zanotto PM, Leite LC (2018) The challenges imposed by Dengue, Zika, and Chikungunya to Brazil. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01964","journal-title":"Front Immunol"},{"issue":"12","key":"1898_CR8","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"MG Guzman","year":"2010","unstructured":"Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Mart\u00ednez E, Nathan MB (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12):S7-16","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"1898_CR9","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Y Modis","year":"2003","unstructured":"Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci 100(12):6986\u20136991","journal-title":"Proc Natl Acad Sci"},{"issue":"30","key":"1898_CR10","doi-asserted-by":"publisher","first-page":"17992","DOI":"10.1073\/pnas.2003056117","volume":"117","author":"H Xia","year":"2020","unstructured":"Xia H, Xie X, Zou J, Noble CG, Russell WK, Holthauzen LM, Choi KH, White MA, Shi PY (2020) A cocrystal structure of dengue capsid protein in complex of inhibitor. Proc Natl Acad Sci 117(30):17992\u201318001","journal-title":"Proc Natl Acad Sci"},{"issue":"5871","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","volume":"319","author":"L Li","year":"2008","unstructured":"Li L, Lok SM, Yu IM, Zhang Y, Kuhn RJ, Chen J, Rossmann MG (2008) The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319(5871):1830\u20131834","journal-title":"Science"},{"issue":"1","key":"1898_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","volume":"57","author":"CM Byrd","year":"2013","unstructured":"Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E (2013) A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 57(1):15\u201325","journal-title":"Antimicrob Agents Chemother"},{"key":"1898_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","volume":"155","author":"JL Smith","year":"2018","unstructured":"Smith JL, Sheridan K, Parkins CJ, Frueh L, Jemison AL, Strode K, Dow G, Nilsen A, Hirsch AJ (2018) Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions. Antiviral Res 155:12\u201319","journal-title":"Antiviral Res"},{"issue":"4","key":"1898_CR14","doi-asserted-by":"publisher","first-page":"e1002627","DOI":"10.1371\/journal.ppat.1002627","volume":"8","author":"AG Schmidt","year":"2012","unstructured":"Schmidt AG, Lee K, Yang PL, Harrison SC (2012) Small-molecule inhibitors of dengue-virus entry. PLoS Pathog 8(4):e1002627","journal-title":"PLoS Pathog"},{"issue":"5","key":"1898_CR15","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","volume":"2","author":"JM Yang","year":"2007","unstructured":"Yang JM, Chen YF, Tu YY, Yen KR, Yang YL (2007) Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS ONE 2(5):e428","journal-title":"PLoS ONE"},{"issue":"3","key":"1898_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","volume":"84","author":"MK Poh","year":"2009","unstructured":"Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W (2009) A small molecule fusion inhibitor of dengue virus. Antiviral Res 84(3):260\u2013266","journal-title":"Antiviral Res"},{"key":"1898_CR17","doi-asserted-by":"publisher","first-page":"111628","DOI":"10.1016\/j.ejmech.2019.111628","volume":"182","author":"ES Leal","year":"2019","unstructured":"Leal ES, Adler NS, Fern\u00e1ndez GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, de Los R\u00edos AH, D\u00e1vila JA, Morell ML (2019) De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Eur J Med Chem 182:111628","journal-title":"Eur J Med Chem"},{"issue":"12","key":"1898_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/cb800176t","volume":"3","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB (2008) Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 3(12):765\u2013775","journal-title":"ACS Chem Biol"},{"issue":"2","key":"1898_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","volume":"88","author":"D Kato","year":"2010","unstructured":"Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T (2010) Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Antiviral Res 88(2):236\u2013243","journal-title":"Antiviral Res"},{"issue":"1","key":"1898_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0166-3542(02)00095-5","volume":"56","author":"YL Lin","year":"2002","unstructured":"Lin YL, Lei HY, Lin YS, Yeh TM, Chen SH, Liu HS (2002) Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res 56(1):93\u201396","journal-title":"Antiviral Res"},{"issue":"1","key":"1898_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","volume":"376","author":"KI Hidari","year":"2008","unstructured":"Hidari KI, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T (2008) Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun 376(1):91\u201395","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1898_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.virol.2007.01.043","volume":"363","author":"LB Talarico","year":"2007","unstructured":"Talarico LB, Damonte EB (2007) Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363(2):473\u2013485","journal-title":"Virology"},{"issue":"1","key":"1898_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","volume":"69","author":"E Lee","year":"2006","unstructured":"Lee E, Pavy M, Young N, Freeman C, Lobigs M (2006) Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res 69(1):31\u201338","journal-title":"Antiviral Res"},{"issue":"1","key":"1898_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-13-187","volume":"13","author":"LT Lin","year":"2013","unstructured":"Lin LT, Chen TY, Lin SC, Chung CY, Lin TC, Wang GH, Anderson R, Lin CC, Richardson CD (2013) Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol 13(1):1\u20135","journal-title":"BMC Microbiol"},{"issue":"2","key":"1898_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/cb500640t","volume":"10","author":"AF Faustino","year":"2015","unstructured":"Faustino AF, Guerra GM, Huber RG, Hollmann A, Domingues MM, Barbosa GM, Enguita FJ, Bond PJ, Castanho MA, Da Poian AT, Almeida FC (2015) Understanding dengue virus capsid protein disordered N-terminus and pep14-23-based inhibition. ACS Chem Biol 10(2):517\u2013526","journal-title":"ACS Chem Biol"},{"issue":"24","key":"1898_CR26","doi-asserted-by":"publisher","first-page":"13094","DOI":"10.1128\/JVI.00704-13","volume":"87","author":"CA Balinsky","year":"2013","unstructured":"Balinsky CA, Schmeisser H, Ganesan S, Singh K, Pierson TC, Zoon KC (2013) Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J Virol 87(24):13094\u201313106","journal-title":"J Virol"},{"issue":"8","key":"1898_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/abbs\/36.8.577","volume":"36","author":"CF Qin","year":"2004","unstructured":"Qin CF, Qin ED (2004) Development of cell lines stably expressing staphylococcal nuclease fused to dengue 2 virus capsid protein for CTVI. Acta Biochim Biophys Sin 36(8):577\u2013582","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"1898_CR28","doi-asserted-by":"publisher","first-page":"e1000851","DOI":"10.1371\/journal.ppat.1000851","volume":"6","author":"AG Schmidt","year":"2010","unstructured":"Schmidt AG, Yang PL, Harrison SC (2010) Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6(4):e1000851","journal-title":"PLoS Pathog"},{"issue":"1","key":"1898_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-2-49","volume":"2","author":"YM Hrobowski","year":"2005","unstructured":"Hrobowski YM, Garry RF, Michael SF (2005) Peptide inhibitors of dengue virus and West Nile virus infectivity. Virology J 2(1):1","journal-title":"Virology J"},{"issue":"1","key":"1898_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10867-018-9515-6","volume":"45","author":"DM Isa","year":"2019","unstructured":"Isa DM, Chin SP, Chong WL, Zain SM, Abd Rahman N, Lee VS (2019) Dynamics and binding interactions of peptide inhibitors of dengue virus entry. J Biol Phys 45(1):63\u201376","journal-title":"J Biol Phys"},{"issue":"6","key":"1898_CR31","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","volume":"4","author":"JM Costin","year":"2010","unstructured":"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF (2010) Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis 4(6):e721","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1898_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","volume":"86","author":"A Panya","year":"2015","unstructured":"Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT (2015) A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Chem Biol Drug Des 86(5):1093\u20131104","journal-title":"Chem Biol Drug Des"},{"issue":"11","key":"1898_CR33","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.1322036111","volume":"111","author":"MA Edeling","year":"2014","unstructured":"Edeling MA, Diamond MS, Fremont DH (2014) Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci 111(11):4285\u20134290","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"1898_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1086\/343813","volume":"186","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S et al (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186(8):1165\u20131168. https:\/\/doi.org\/10.1086\/343813","journal-title":"J Infect Dis"},{"issue":"1","key":"1898_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-69515-9","volume":"10","author":"P Songprakhon","year":"2020","unstructured":"Songprakhon P, Thaingtamtanha T, Limjindaporn T, Puttikhunt C, Srisawat C, Luangaram P, Dechtawewat T, Uthaipibull C, Thongsima S, Yenchitsomanus PT, Malasit P (2020) Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production. Sci Rep 10(1):1\u20136","journal-title":"Sci Rep"},{"issue":"6","key":"1898_CR36","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1128\/JVI.02044-09","volume":"84","author":"S Chandramouli","year":"2010","unstructured":"Chandramouli S, Joseph JS, Daudenarde S, Gatchalian J, Cornillez-Ty C, Kuhn P (2010) Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol 84(6):3059\u20133067","journal-title":"J Virol"},{"issue":"1","key":"1898_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-314","volume":"12","author":"HA Rothan","year":"2012","unstructured":"Rothan HA, Han HC, Ramasamy TS, Othman S, Abd Rahman N, Yusof R (2012) Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis 12(1):1\u20139","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1898_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/AAC.01281-13","volume":"58","author":"CC Yang","year":"2014","unstructured":"Yang CC, Hu HS, Wu RH, Wu SH, Lee SJ, Jiaang WT, Chern JH, Huang ZS, Wu HN, Chang CM, Yueh A (2014) A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B\/NS3 protease. Antimicrob Agents Chemother 58(1):110\u2013119","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1898_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","volume":"82","author":"SM Tomlinson","year":"2009","unstructured":"Tomlinson SM, Malmstrom RD, Russo A, Mueller N, Pang YP, Watowich SJ (2009) Structure-based discovery of dengue virus protease inhibitors. Antiviral Res 82(3):110\u2013114","journal-title":"Antiviral Res"},{"issue":"20","key":"1898_CR40","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1128\/JVI.75.20.9633-9643.2001","volume":"75","author":"AE Matusan","year":"2001","unstructured":"Matusan AE, Pryor MJ, Davidson AD, Wright PJ (2001) Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol 75(20):9633\u20139643","journal-title":"J Virol"},{"issue":"22","key":"1898_CR41","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.1093\/nar\/gkx1127","volume":"45","author":"CM Swarbrick","year":"2017","unstructured":"Swarbrick CM, Basavannacharya C, Chan KW, Chan SA, Singh D, Wei N, Phoo WW, Luo D, Lescar J, Vasudevan SG (2017) NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication. Nucleic Acids Res 45(22):12904\u201312920","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1898_CR42","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","volume":"67","author":"E Mastrangelo","year":"2012","unstructured":"Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M (2012) Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother 67(8):1884\u20131894","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1898_CR43","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.02251-12","volume":"57","author":"CM Byrd","year":"2013","unstructured":"Byrd CM, Grosenbach DW, Berhanu A, Dai D, Jones KF, Cardwell KB, Schneider C, Yang G, Tyavanagimatt S, Harver C, Wineinger KA (2013) Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother 57(4):1902\u20131912","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1898_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","volume":"453","author":"C Basavannacharya","year":"2014","unstructured":"Basavannacharya C, Vasudevan SG (2014) Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format. Biochem Biophys Res Commun 453(3):539\u2013544","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1898_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21315\/mjms2018.25.5.2","volume":"25","author":"H Norazharuddin","year":"2018","unstructured":"Norazharuddin H, Lai NS (2018) Roles and prospects of dengue virus non-structural proteins as antiviral targets: an easy digest. Malays J Med Sci 25(5):6","journal-title":"Malays J Med Sci"},{"issue":"4","key":"1898_CR46","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1128\/AAC.02462-15","volume":"60","author":"KW van Cleef","year":"2016","unstructured":"van Cleef KW, Overheul GJ, Thomassen MC, Marjakangas JM, van Rij RP (2016) Escape mutations in NS4B render dengue virus insensitive to the antiviral activity of the paracetamol metabolite AM404. Antimicrob Agents Chemother 60(4):2554\u20132557","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"1898_CR47","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1128\/JVI.05468-11","volume":"85","author":"X Xie","year":"2011","unstructured":"Xie X, Wang QY, Xu HY, Qing M, Kramer L, Yuan Z, Shi PY (2011) Inhibition of dengue virus by targeting viral NS4B protein. J Virol 85(21):11183\u201311195","journal-title":"J Virol"},{"issue":"9","key":"1898_CR48","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","volume":"207","author":"NM Nguyen","year":"2013","unstructured":"Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh HL, Farrar J, Nguyen QT, Tran HT, Nguyen CV, Merson L, Hoang LT (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207(9):1442\u20131450","journal-title":"J Infect Dis"},{"issue":"1","key":"1898_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1128\/AAC.04177-14","volume":"59","author":"M Carocci","year":"2015","unstructured":"Carocci M, Hinshaw SM, Rodgers MA, Villareal VA, Burri DJ, Pilankatta R, Maharaj NP, Gack MU, Stavale EJ, Warfield KL, Yang PL (2015) The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob Agents Chemother 59(1):85\u201395","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1898_CR50","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","volume":"59","author":"F Yokokawa","year":"2016","unstructured":"Yokokawa F, Nilar S, Noble CG, Lim SP, Rao R, Tania S, Wang G, Lee G, Hunziker J, Karuna R, Manjunatha U (2016) Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design. J Med Chem 59(8):3935\u20133952","journal-title":"J Med Chem"},{"key":"1898_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8727-1_14","author":"SP Lim","year":"2018","unstructured":"Lim SP, Noble CG, Nilar S, Shi PY, Yokokawa F (2018) Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design. Dengue Zika: Control Antivir Treat Strateg. https:\/\/doi.org\/10.1007\/978-981-10-8727-1_14","journal-title":"Dengue Zika: Control Antivir Treat Strateg"},{"key":"1898_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","volume":"125","author":"F Benmansour","year":"2017","unstructured":"Benmansour F, Trist I, Coutard B, Decroly E, Querat G, Brancale A, Barral K (2017) Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem 125:865\u2013880","journal-title":"Eur J Med Chem"},{"key":"1898_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/82_2020_195","author":"N Haese","year":"2020","unstructured":"Haese N, Powers J, Streblow DN (2020) Small molecule inhibitors targeting chikungunya virus. Chikungunya Virus. https:\/\/doi.org\/10.1007\/82_2020_195","journal-title":"Chikungunya Virus"},{"key":"1898_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2016.08.029","volume":"498","author":"R Sharma","year":"2016","unstructured":"Sharma R, Fatma B, Saha A, Bajpai S, Sistla S, Dash PK, Parida M, Kumar P, Tomar S (2016) Inhibition of chikungunya virus by picolinate that targets viral capsid protein. Virology 498:265\u2013276","journal-title":"Virology"},{"key":"1898_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2021.05.013","volume":"561","author":"R Kumar","year":"2021","unstructured":"Kumar R, Nehul S, Singh A, Tomar S (2021) Identification and evaluation of antiviral potential of thymoquinone, a natural compound targeting Chikungunya virus capsid protein. Virology 561:36\u201346","journal-title":"Virology"},{"key":"1898_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.virol.2017.12.020","volume":"515","author":"R Sharma","year":"2018","unstructured":"Sharma R, Kesari P, Kumar P, Tomar S (2018) Structure-function insights into chikungunya virus capsid protein: small molecules targeting capsid hydrophobic pocket. Virology 515:223\u2013234","journal-title":"Virology"},{"key":"1898_CR57","doi-asserted-by":"publisher","first-page":"104808","DOI":"10.1016\/j.antiviral.2020.104808","volume":"179","author":"B Fatma","year":"2020","unstructured":"Fatma B, Kumar R, Singh VA, Nehul S, Sharma R, Kesari P, Kuhn RJ, Tomar S (2020) Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection. Antiviral Res 179:104808","journal-title":"Antiviral Res"},{"issue":"1","key":"1898_CR58","doi-asserted-by":"publisher","first-page":"e0005318","DOI":"10.1371\/journal.pntd.0005318","volume":"11","author":"C Weber","year":"2017","unstructured":"Weber C, Berberich E, von Rhein C, Hen\u00df L, Hildt E, Schnierle BS (2017) Identification of functional determinants in the chikungunya virus E2 protein. PLoS Negl Trop Dis 11(1):e0005318","journal-title":"PLoS Negl Trop Dis"},{"issue":"18","key":"1898_CR59","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1128\/JVI.01507-13","volume":"87","author":"O Uchime","year":"2013","unstructured":"Uchime O, Fields W, Kielian M (2013) The role of E3 in pH protection during alphavirus assembly and exit. J Virol 87(18):10255\u201310262","journal-title":"J Virol"},{"issue":"7324","key":"1898_CR60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature09555","volume":"468","author":"JE Voss","year":"2010","unstructured":"Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA (2010) Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468(7324):709\u2013712","journal-title":"Nature"},{"issue":"3","key":"1898_CR61","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12539-016-0209-0","volume":"10","author":"PT Nguyen","year":"2018","unstructured":"Nguyen PT, Yu H, Keller PA (2018) Molecular docking studies to explore potential binding pockets and inhibitors for chikungunya virus envelope glycoproteins. Interdiscip Sci: Comput Life Sci 10(3):515\u2013524","journal-title":"Interdiscip Sci: Comput Life Sci"},{"issue":"7","key":"1898_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/ph13070141","volume":"13","author":"GF Passos","year":"2020","unstructured":"Passos GF, Gomes MG, Aquino TM, Ara\u00fajo-J\u00fanior JX, Souza SJ, Cavalcante JP, Santos EC, Bassi \u00caJ, Silva-J\u00fanior EF (2020) Computer-aided design, synthesis, and antiviral evaluation of novel acrylamides as potential inhibitors of E3-E2-E1 glycoproteins complex from Chikungunya virus. Pharmaceuticals 13(7):141","journal-title":"Pharmaceuticals"},{"issue":"14","key":"1898_CR63","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1021\/acsomega.1c00447","volume":"6","author":"M Islamuddin","year":"2021","unstructured":"Islamuddin M, Afzal O, Khan WH, Hisamuddin M, Altamimi AS, Husain I, Kato K, Alamri MA, Parveen S (2021) Inhibition of Chikungunya Virus Infection by 4-Hydroxy-1-Methyl-3-(3-morpholinopropanoyl) quinoline-2 (1 H)-one (QVIR) Targeting nsP2 and E2 Proteins. ACS Omega 6(14):9791\u20139803","journal-title":"ACS Omega"},{"issue":"7","key":"1898_CR64","doi-asserted-by":"publisher","first-page":"e0007548","DOI":"10.1371\/journal.pntd.0007548","volume":"13","author":"D Dey","year":"2019","unstructured":"Dey D, Siddiqui SI, Mamidi P, Ghosh S, Kumar CS, Chattopadhyay S, Ghosh S, Banerjee M (2019) The effect of amantadine on an ion channel protein from Chikungunya virus. PLoS Negl Trop Dis 13(7):e0007548","journal-title":"PLoS Negl Trop Dis"},{"issue":"Pt 9","key":"1898_CR65","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1099\/jgv.0.000249","volume":"96","author":"JC Rupp","year":"2015","unstructured":"Rupp JC, Sokoloski KJ, Gebhart NN, Hardy RW (2015) Alphavirus RNA synthesis and non-structural protein functions. J Gen Virol 96(Pt 9):2483","journal-title":"J Gen Virol"},{"key":"1898_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","volume":"154","author":"KM Feibelman","year":"2018","unstructured":"Feibelman KM, Fuller BP, Li L, LaBarbera DV, Geiss BJ (2018) Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme. Antivir Res 154:124\u2013131","journal-title":"Antivir Res"},{"issue":"10","key":"1898_CR67","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1021\/jm401844c","volume":"57","author":"A Gigante","year":"2014","unstructured":"Gigante A, Canela MD, Delang L, Priego EM, Camarasa MJ, Querat G, Neyts J, Leyssen P, P\u00e9rez-P\u00e9rez MJ (2014) Identification of [1, 2, 3] triazolo [4, 5-d] pyrimidin-7 (6 H)-ones as novel inhibitors of Chikungunya virus replication. J Med Chem 57(10):4000\u20134008","journal-title":"J Med Chem"},{"issue":"4","key":"1898_CR68","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/1873-3468.13642","volume":"594","author":"R Mudgal","year":"2020","unstructured":"Mudgal R, Mahajan S, Tomar S (2020) Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase. FEBS Lett 594(4):678\u2013694","journal-title":"FEBS Lett"},{"issue":"4","key":"1898_CR69","doi-asserted-by":"publisher","first-page":"e02532","DOI":"10.1128\/AAC.02532-19","volume":"64","author":"K Kovacikova","year":"2020","unstructured":"Kovacikova K, Morren BM, Tas A, Albulescu IC, van Rijswijk R, Jarhad DB, Shin YS, Jang MH, Kim G, Lee HW, Jeong LS (2020) 6\u2032-\u03b2-Fluoro-homoaristeromycin and 6\u2032-fluoro-homoneplanocin A are potent inhibitors of chikungunya virus replication through their direct effect on viral nonstructural protein 1. Antimicrob Agents Chemother 64(4):e02532-e2619","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1898_CR70","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1021\/acsmedchemlett.9b00662","volume":"11","author":"J Moesslacher","year":"2020","unstructured":"Moesslacher J, Battisti V, Delang L, Neyts J, Abdelnabi R, P\u00fcrstinger G, Urban E, Langer T (2020) Identification of 2-(4-(phenylsulfonyl) piperazine-1-yl) pyrimidine analogues as novel inhibitors of chikungunya virus. ACS Med Chem Lett 11(5):906\u2013912","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"1898_CR71","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.chom.2021.02.018","volume":"29","author":"K Zhang","year":"2021","unstructured":"Zhang K, Law YS, Law MC, Tan YB, Wirawan M, Luo D (2021) Structural insights into viral RNA capping and plasma membrane targeting by Chikungunya virus nonstructural protein 1. Cell Host Microbe 29(5):757\u2013764","journal-title":"Cell Host Microbe"},{"issue":"7","key":"1898_CR72","doi-asserted-by":"publisher","first-page":"e02566","DOI":"10.1128\/AAC.02566-20","volume":"65","author":"K Kovacikova","year":"2021","unstructured":"Kovacikova K, Gorostiola Gonz\u00e1lez M, Jones R, Reguera J, Gigante A, P\u00e9rez-P\u00e9rez MJ, P\u00fcrstinger G, Moesslacher J, Langer T, Jeong LS, Delang L (2021) Structural insights into the mechanisms of action of functionally distinct classes of Chikungunya virus nonstructural protein 1 inhibitors. Antimicrob Agents Chemother 65(7):e02566-e2620","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"1898_CR73","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.1128\/JVI.00884-13","volume":"87","author":"JJ Fros","year":"2013","unstructured":"Fros JJ, van der Maten E, Vlak JM, Pijlman GP (2013) The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling. J Virol 87(18):10394\u201310400","journal-title":"J Virol"},{"key":"1898_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijbiomac.2018.05.007","volume":"116","author":"M Narwal","year":"2018","unstructured":"Narwal M, Singh H, Pratap S, Malik A, Kuhn RJ, Kumar P, Tomar S (2018) Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site. Int J Biol Macromol 116:451\u2013462","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1898_CR75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2013.01.002","volume":"98","author":"M Bassetto","year":"2013","unstructured":"Bassetto M, De Burghgraeve T, Delang L, Massarotti A, Coluccia A, Zonta N, Gatti V, Colombano G, Sorba G, Silvestri R, Tron GC (2013) Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Antivir Res 98(1):12\u201318","journal-title":"Antivir Res"},{"key":"1898_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmgm.2015.01.001","volume":"57","author":"PT Nguyen","year":"2015","unstructured":"Nguyen PT, Yu H, Keller PA (2015) Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches. J Mol Graph Model 57:1\u20138","journal-title":"J Mol Graph Model"},{"issue":"4","key":"1898_CR77","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/0250-474X.164769","volume":"77","author":"T Agarwal","year":"2015","unstructured":"Agarwal T, Asthana S, Bissoyi A (2015) Molecular modeling and docking study to elucidate novel chikungunya virus nsP2 protease inhibitors. Indian J Pharm Sci 77(4):453","journal-title":"Indian J Pharm Sci"},{"key":"1898_CR78","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.12688\/f1000research.12301.2","volume":"6","author":"J Jain","year":"2017","unstructured":"Jain J, Kumari A, Somvanshi P, Grover A, Pai S, Sunil S (2017) In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus. F1000Research 6:1601","journal-title":"F1000Research"},{"issue":"3","key":"1898_CR79","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/pathogens8030128","volume":"8","author":"P Kumar","year":"2019","unstructured":"Kumar P, Kumar D, Giri R (2019) Targeting the nsp2 cysteine protease of chikungunya virus using FDA approved library and selected cysteine protease inhibitors. Pathogens 8(3):128","journal-title":"Pathogens"},{"key":"1898_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1873863","author":"MK Meena","year":"2021","unstructured":"Meena MK, Kumar D, Kumari K, Kaushik NK, Kumar RV, Bahadur I, Vodwal L, Singh P (2021) Promising inhibitors of nsp2 of CHIKV using molecular docking and temperature-dependent molecular dynamics simulations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1873863","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"1898_CR81","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1570163817666200312102659","volume":"18","author":"N Rasool","year":"2021","unstructured":"Rasool N, Bakht A, Hussain W (2021) Analysis of inhibitor binding combined with reactivity studies to discover the potentially inhibiting phytochemicals targeting Chikungunya viral replication. Curr Drug Discov Technol 18(3):437\u2013450","journal-title":"Curr Drug Discov Technol"},{"issue":"3","key":"1898_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2217\/fvl-2019-0090","volume":"16","author":"R Lani","year":"2021","unstructured":"Lani R, Agharbaoui FE, Hassandarvish P, Teoh BT, Sam SS, Zandi K, Rahman NA, AbuBakar S (2021) In silico studies of fisetin and silymarin as novel chikungunya virus nonstructural proteins inhibitors. Future Virol 16(3):167\u2013180","journal-title":"Future Virol"},{"issue":"4","key":"1898_CR83","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1570180811666141001005402","volume":"12","author":"S Singh Jadav","year":"2015","unstructured":"Singh Jadav S, Nayan Sinha B, Pastorino B, de Lamballerie X, Hilgenfeld R, Jayaprakash V (2015) Identification of pyrazole derivative as an antiviral agent against Chikungunya through HTVS. Lett Drug Des Discov 12(4):292\u2013301","journal-title":"Lett Drug Des Discov"},{"issue":"12","key":"1898_CR84","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.1128\/AAC.01421-16","volume":"60","author":"PK Das","year":"2016","unstructured":"Das PK, Puusepp L, Varghese FS, Utt A, Ahola T, Kananovich DG, Lopp M, Merits A, Karelson M (2016) Design and validation of novel chikungunya virus protease inhibitors. Antimicrob Agents Chemother 60(12):7382\u20137395","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1898_CR85","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.1021\/acsomega.0c06191","volume":"6","author":"L Ivanova","year":"2021","unstructured":"Ivanova L, Rausalu K, \u017dusinaite E, Tammiku-Taul J, Merits A, Karelson M (2021) 1, 3-Thiazolbenzamide derivatives as Chikungunya virus nsP2 protease inhibitors. ACS Omega 6(8):5786\u20135794","journal-title":"ACS Omega"},{"issue":"3","key":"1898_CR86","doi-asserted-by":"publisher","first-page":"e0246319","DOI":"10.1371\/journal.pone.0246319","volume":"16","author":"RJ Eberle","year":"2021","unstructured":"Eberle RJ, Olivier DS, Pacca CC, Avilla CM, Nogueira ML, Amaral MS, Willbold D, Arni RK, Coronado MA (2021) In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases. PLoS ONE 16(3):e0246319","journal-title":"PLoS ONE"},{"key":"1898_CR87","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.virol.2020.05.010","volume":"548","author":"PK Tripathi","year":"2020","unstructured":"Tripathi PK, Soni A, Yadav SP, Kumar A, Gaurav N, Raghavendhar S, Sharma P, Sunil S, Jayaram B, Patel AK (2020) Evaluation of novobiocin and telmisartan for anti-CHIKV activity. Virology 548:250\u2013260","journal-title":"Virology"},{"key":"1898_CR88","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijbiomac.2020.05.165","volume":"160","author":"PK Tripathi","year":"2020","unstructured":"Tripathi PK, Singh J, Gaurav N, Garg DK, Patel AK (2020) In-silico and biophysical investigation of biomolecular interaction between naringin and nsP2 of the chikungunya virus. Int J Biol Macromol 160:1061\u20131065","journal-title":"Int J Biol Macromol"},{"key":"1898_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biochi.2018.04.004","volume":"149","author":"H Singh","year":"2018","unstructured":"Singh H, Mudgal R, Narwal M, Kaur R, Singh VA, Malik A, Chaudhary M, Tomar S (2018) Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease. Biochimie 149:51\u201361","journal-title":"Biochimie"},{"issue":"6","key":"1898_CR90","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/cbdd.12621","volume":"86","author":"EM El-labbad","year":"2015","unstructured":"El-labbad EM, Ismail MA, Abou Ei Ella DA, Ahmed M, Wang F, Barakat KH, Abouzid KA (2015) Discovery of novel peptidomimetics as irreversible CHIKV Ns P 2 protease inhibitors using quantum mechanical-based ligand descriptors. Chem Biol Drug Des 86(6):1518\u20131527","journal-title":"Chem Biol Drug Des"},{"issue":"19","key":"1898_CR91","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1073\/pnas.1900656116","volume":"116","author":"YS Law","year":"2019","unstructured":"Law YS, Utt A, Tan YB, Zheng J, Wang S, Chen MW, Griffin PR, Merits A, Luo D (2019) Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase. Proc Natl Acad Sci 116(19):9558\u20139567","journal-title":"Proc Natl Acad Sci"},{"issue":"44","key":"1898_CR92","doi-asserted-by":"publisher","first-page":"E10457","DOI":"10.1073\/pnas.1812130115","volume":"115","author":"R Abraham","year":"2018","unstructured":"Abraham R, Hauer D, McPherson RL, Utt A, Kirby IT, Cohen MS, Merits A, Leung AK, Griffin DE (2018) ADP-ribosyl\u2013binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication. Proc Natl Acad Sci 115(44):E10457\u2013E10466","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"1898_CR93","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1128\/JVI.00189-09","volume":"83","author":"H Malet","year":"2009","unstructured":"Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, Neuvonen M, Ahola T, Forrester N, Gould EA, Lafitte D, Ferron F (2009) The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol 83(13):6534\u20136545","journal-title":"J Virol"},{"issue":"1","key":"1898_CR94","doi-asserted-by":"publisher","first-page":"e0245013","DOI":"10.1371\/journal.pone.0245013","volume":"16","author":"S Zhang","year":"2021","unstructured":"Zhang S, Garzan A, Haese N, Bostwick R, Martinez-Gzegozewska Y, Rasmussen L, Streblow DN, Haise MT, Pathak AK, Augelli-Szafran CE, Wu M (2021) Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design. PLoS ONE 16(1):e0245013","journal-title":"PLoS ONE"},{"key":"1898_CR95","doi-asserted-by":"publisher","first-page":"105490","DOI":"10.1016\/j.actatropica.2020.105490","volume":"207","author":"JF Shimizu","year":"2020","unstructured":"Shimizu JF, Martins DO, McPhillie MJ, Roberts GC, Zothner C, Merits A, Harris M, Jardim AC (2020) Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches? Acta Trop 207:105490","journal-title":"Acta Trop"},{"issue":"5","key":"1898_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2216-6","volume":"20","author":"PT Nguyen","year":"2014","unstructured":"Nguyen PT, Yu H, Keller PA (2014) Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus. J Mol Model 20(5):1\u20132","journal-title":"J Mol Model"},{"issue":"10","key":"1898_CR97","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1080\/07391102.2019.1650830","volume":"38","author":"D Kumar","year":"2020","unstructured":"Kumar D, Kumari K, Jayaraj A, Singh P (2020) Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles. J Biomol Struct Dyn 38(10):3018\u20133034","journal-title":"J Biomol Struct Dyn"},{"key":"1898_CR98","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1832918","author":"MK Meena","year":"2020","unstructured":"Meena MK, Kumar D, Jayaraj A, Kumar A, Kumari K, Katata-Seru LM, Bahadur I, Kumar V, Sherawat A, Singh P (2020) Designed thiazolidines: an arsenal for the inhibition of nsP3 of CHIKV using molecular docking and MD simulations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1832918","journal-title":"J Biomol Struct Dyn"},{"issue":"8","key":"1898_CR99","doi-asserted-by":"publisher","first-page":"e04720","DOI":"10.1016\/j.heliyon.2020.e04720","volume":"6","author":"D Kumar","year":"2020","unstructured":"Kumar D, Meena MK, Kumari K, Patel R, Jayaraj A, Singh P (2020) In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation. Heliyon 6(8):e04720","journal-title":"Heliyon"},{"key":"1898_CR100","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1960195","author":"M Chaudhary","year":"2021","unstructured":"Chaudhary M, Sehgal D (2021) In silico identification of natural antiviral compounds as a potential inhibitor of chikungunya virus non-structural protein 3 macrodomain. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1960195","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"1898_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-021-01517-z","volume":"18","author":"P Patil","year":"2021","unstructured":"Patil P, Agrawal M, Almelkar S, Jeengar MK, More A, Alagarasu K, Kumar NV, Mainkar PS, Parashar D, Cherian S (2021) In vitro and in vivo studies reveal \u03b1-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus. Virol J 18(1):1\u20132","journal-title":"Virol J"},{"issue":"9","key":"1898_CR102","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1128\/jvi.68.9.5781-5791.1994","volume":"68","author":"MW LaStarza","year":"1994","unstructured":"LaStarza MW, Lemm JA, Rice CM (1994) Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis. J Virol 68(9):5781\u20135791","journal-title":"J Virol"},{"issue":"6","key":"1898_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-019-1759-8","volume":"9","author":"I Nandi","year":"2019","unstructured":"Nandi I, Gupta A, Chaudhary VK, Gupta V, Gabrani R, Gupta S (2019) Expression, purification and functional characterization of recombinant hypervariable region (HVR) of Chikungunya virus nsP3 protein. 3 Biotech 9(6):1\u20138","journal-title":"3 Biotech"},{"issue":"4","key":"1898_CR104","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1573409911666150407161535","volume":"10","author":"G Satheesh","year":"2014","unstructured":"Satheesh G, Prabhu PN, Venkataramana M (2014) 3D Modeling of dengue virus NS4B and Chikungunya virus nsP4: identification of a common drug target and designing a single antiviral inhibitor. Curr Comput Aided Drug Des 10(4):361\u2013373","journal-title":"Curr Comput Aided Drug Des"},{"issue":"9","key":"1898_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-021-04868-0","volume":"27","author":"A Reyes-Gastellou","year":"2021","unstructured":"Reyes-Gastellou A, Jim\u00e9nez-Alberto A, Castel\u00e1n-Vega JA, Aparicio-Ozores G, Ribas-Aparicio RM (2021) Chikungunya nsP4 homology modeling reveals a common motif with Zika and Dengue RNA polymerases as a potential therapeutic target. J Mol Model 27(9):1\u20132","journal-title":"J Mol Model"},{"key":"1898_CR106","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.virol.2017.02.014","volume":"505","author":"Y Wada","year":"2017","unstructured":"Wada Y, Orba Y, Sasaki M, Kobayashi S, Carr MJ, Nobori H, Sato A, Hall WW, Sawa H (2017) Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Virology 505:102\u2013112","journal-title":"Virology"},{"issue":"4","key":"1898_CR107","doi-asserted-by":"publisher","first-page":"e02395","DOI":"10.1128\/AAC.02395-16","volume":"61","author":"M Ehteshami","year":"2017","unstructured":"Ehteshami M, Tao S, Zandi K, Hsiao HM, Jiang Y, Hammond E, Amblard F, Russell OO, Merits A, Schinazi RF (2017) Characterization of \u03b2-d-N 4-hydroxycytidine as a novel inhibitor of chikungunya virus. Antimicrob Agents Chemother 61(4):e02395-e2416","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1898_CR108","doi-asserted-by":"publisher","first-page":"e01389-18","DOI":"10.1128\/AAC.01389-18","volume":"63","author":"AC Ferreira","year":"2019","unstructured":"Ferreira AC, Reis PA, de Freitas CS, Sacramento CQ, Villas B\u00f4as Hoelz L, Bastos MM, Mattos M, Rocha N, Gomes de Azevedo Quintanilha I, da Silva Gouveia Pedrosa C, Rocha Quintino Souza L (2019) Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication. Antimicrob Agents Chemother 63(2):e01389-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1898_CR109","first-page":"1752","volume":"3","author":"SP Kumar","year":"2012","unstructured":"Kumar SP, Kapopara RG, Patni MI, Pandya HA, Jasrai YT, Patel SK (2012) Exploring the polymerase activity of chikungunya viral non structural protein 4 (nsP4) using molecular modeling, epharmacophore and docking studies. Int J Pharm Life Sci 3(6):1752\u20131765","journal-title":"Int J Pharm Life Sci"},{"issue":"3","key":"1898_CR110","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13337-019-00547-0","volume":"30","author":"R Ghildiyal","year":"2019","unstructured":"Ghildiyal R, Gupta S, Gabrani R, Joshi G, Gupta A, Chaudhary VK, Gupta V (2019) In silico study of chikungunya polymerase, a potential target for inhibitors. Virusdisease 30(3):394\u2013402","journal-title":"Virusdisease"},{"issue":"1","key":"1898_CR111","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13071-019-3461-4","volume":"12","author":"CF Ayres","year":"2019","unstructured":"Ayres CF, Guedes DR, Paiva MH, Morais-Sobral MC, Krokovsky L, Machado LC, Melo-Santos MA, Crespo M, Oliveira CM, Ribeiro RS, Cardoso OA (2019) Zika virus detection, isolation and genome sequencing through Culicidae sampling during the epidemic in Vit\u00f3ria, Esp\u00edrito Santo, Brazil. Parasit Vectors 12(1):220","journal-title":"Parasit Vectors"},{"issue":"7","key":"1898_CR112","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jmb.2018.02.006","volume":"430","author":"Z Shang","year":"2018","unstructured":"Shang Z, Song H, Shi Y, Qi J, Gao GF (2018) Crystal structure of the capsid protein from Zika virus. J Mol Biol 430(7):948\u2013962","journal-title":"J Mol Biol"},{"key":"1898_CR113","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.11.378083","author":"SR Ahmed","year":"2020","unstructured":"Ahmed SR, Banik A, Anni SM, Chowdhury MM (2020) Plant derived bioactive compounds as potential inhibitors of ZIKA virus: an in silico investigation. bioRxiv. https:\/\/doi.org\/10.1101\/2020.11.11.378083","journal-title":"bioRxiv"},{"issue":"5","key":"1898_CR114","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai L, Song J, Lu X, Deng YQ, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, Xiao H (2016) Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19(5):696\u2013704","journal-title":"Cell Host Microbe"},{"issue":"12","key":"1898_CR115","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12033-016-9979-1","volume":"58","author":"S Fernando","year":"2016","unstructured":"Fernando S, Fernando T, Stefanik M, Eyer L, Ruzek D (2016) An approach for Zika virus inhibition using homology structure of the envelope protein. Mol Biotechnol 58(12):801\u2013806","journal-title":"Mol Biotechnol"},{"key":"1898_CR116","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","volume":"496","author":"BM Carneiro","year":"2016","unstructured":"Carneiro BM, Batista MN, Braga AC, Nogueira ML, Rahal P (2016) The green tea molecule EGCG inhibits Zika virus entry. Virology 496:215\u2013218","journal-title":"Virology"},{"issue":"2","key":"1898_CR117","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","volume":"20","author":"NJ Barrows","year":"2016","unstructured":"Barrows NJ, Campos RK, Powell ST, Prasanth KR, Schott-Lerner G, Soto-Acosta R, Galarza-Mu\u00f1oz G, McGrath EL, Urrabaz-Garza R, Gao J, Wu P (2016) A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe 20(2):259\u2013270","journal-title":"Cell Host Microbe"},{"key":"1898_CR118","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2017.03.014","volume":"142","author":"BC Mounce","year":"2017","unstructured":"Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M (2017) Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antivir Res 142:148\u2013157","journal-title":"Antivir Res"},{"issue":"3","key":"1898_CR119","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","volume":"18","author":"K Rausch","year":"2017","unstructured":"Rausch K, Hackett BA, Weinbren NL, Reeder SM, Sadovsky Y, Hunter CA, Schultz DC, Coyne CB, Cherry S (2017) Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus. Cell Rep 18(3):804","journal-title":"Cell Rep"},{"key":"1898_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2018.02.003","volume":"152","author":"AE R\u00f6cker","year":"2018","unstructured":"R\u00f6cker AE, M\u00fcller JA, Dietzel E, Harms M, Kr\u00fcger F, Heid C, Sowislok A, Riber CF, Kupke A, Lippold S, von Einem J (2018) The molecular tweezer CLR01 inhibits Ebola and Zika virus infection. Antiviral Res 152:26\u201335","journal-title":"Antiviral Res"},{"issue":"2","key":"1898_CR121","first-page":"585","volume":"164","author":"A Oo","year":"2019","unstructured":"Oo A, Teoh BT, Sam SS, Bakar SA, Zandi K (2019) Baicalein and baicalin as Zika virus inhibitors. Adv Virol 164(2):585\u2013593","journal-title":"Adv Virol"},{"issue":"11","key":"1898_CR122","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/v11111019","volume":"11","author":"Y Gao","year":"2019","unstructured":"Gao Y, Tai W, Wang N, Li X, Jiang S, Debnath AK, Du L, Chen S (2019) Identification of novel natural products as effective and broad-spectrum anti-Zika virus inhibitors. Viruses 11(11):1019","journal-title":"Viruses"},{"issue":"39","key":"1898_CR123","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1021\/acs.biochem.0c00458","volume":"59","author":"SM Telehany","year":"2020","unstructured":"Telehany SM, Humby MS, McGee TD Jr, Riley SP, Jacobs A, Rizzo RC (2020) Identification of Zika virus inhibitors using homology modeling and similarity-based screening to target glycoprotein E. Biochemistry 59(39):3709\u20133724","journal-title":"Biochemistry"},{"key":"1898_CR124","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2019.02.008","volume":"164","author":"J Pitts","year":"2019","unstructured":"Pitts J, Hsia CY, Lian W, Wang J, Pfeil MP, Kwiatkowski N, Li Z, Jang J, Gray NS, Yang PL (2019) Identification of small molecule inhibitors targeting the Zika virus envelope protein. Antivir Res 164:147\u2013153","journal-title":"Antivir Res"},{"key":"1898_CR125","doi-asserted-by":"publisher","first-page":"104876","DOI":"10.1016\/j.antiviral.2020.104876","volume":"182","author":"N Sharma","year":"2020","unstructured":"Sharma N, Prosser O, Kumar P, Tuplin A, Giri R (2020) Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein. Antivir Res 182:104876","journal-title":"Antivir Res"},{"key":"1898_CR126","doi-asserted-by":"publisher","first-page":"113962","DOI":"10.1016\/j.bcp.2020.113962","volume":"177","author":"M Zou","year":"2020","unstructured":"Zou M, Liu H, Li J, Yao X, Chen Y, Ke C, Liu S (2020) Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection. Biochem Pharmacol 177:113962","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1898_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15672","volume":"8","author":"Y Yu","year":"2017","unstructured":"Yu Y, Deng YQ, Zou P, Wang Q, Dai Y, Yu F, Du L, Zhang NN, Tian M, Hao JN, Meng Y (2017) A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun 8(1):1\u20132","journal-title":"Nat Commun"},{"key":"1898_CR128","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2017.02.009","volume":"141","author":"L Chen","year":"2017","unstructured":"Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W (2017) Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Antivir Res 141:140\u2013149","journal-title":"Antivir Res"},{"issue":"1","key":"1898_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"D Wang","year":"2017","unstructured":"Wang D, Chen C, Liu S, Zhou H, Yang K, Zhao Q, Ji X, Chen C, Xie W, Wang Z, Mi LZ (2017) A mutation identified in neonatal microcephaly destabilizes Zika virus NS1 assembly in vitro. Sci Rep 7(1):1","journal-title":"Sci Rep"},{"issue":"5","key":"1898_CR130","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1109\/TCBB.2019.2911081","volume":"17","author":"S Raza","year":"2019","unstructured":"Raza S, Abbas G, Azam SS (2019) Screening pipeline for Flavivirus based inhibitors for Zika virus NS1. IEEE\/ACM Trans Comput Biol Bioinform 17(5):1751\u20131761","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"8","key":"1898_CR131","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1080\/07391102.2020.1759453","volume":"39","author":"N Ahmad","year":"2021","unstructured":"Ahmad N, Badshah SL, Junaid M, Ur Rehman A, Muhammad A, Khan K (2021) Structural insights into the Zika virus NS1 protein inhibition using a computational approach. J Biomol Struct Dyn 39(8):3004\u20133011","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"1898_CR132","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"P Erbel","year":"2006","unstructured":"Erbel P, Schiering N, D\u2019Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U (2006) Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13(4):372\u2013373","journal-title":"Nat Struct Mol Biol"},{"issue":"6298","key":"1898_CR133","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aag2419","volume":"353","author":"J Lei","year":"2016","unstructured":"Lei J, Hansen G, Nitsche C, Klein CD, Zhang L, Hilgenfeld R (2016) Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor. Science 353(6298):503\u2013505","journal-title":"Science"},{"key":"1898_CR134","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","volume":"145","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan JF, den Haan H, Chik KK, Zhang AJ, Chan CC, Poon VK, Yip CC, Mak WW, Zhu Z, Zou Z (2017) Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antivir Res 145:33\u201343","journal-title":"Antivir Res"},{"issue":"7","key":"1898_CR135","doi-asserted-by":"publisher","first-page":"e0180632","DOI":"10.1371\/journal.pone.0180632","volume":"12","author":"A Roy","year":"2017","unstructured":"Roy A, Lim L, Srivastava S, Lu Y, Song J (2017) Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants. PLoS ONE 12(7):e0180632","journal-title":"PLoS ONE"},{"issue":"8","key":"1898_CR136","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/cr.2017.88","volume":"27","author":"Z Li","year":"2017","unstructured":"Li Z, Brecher M, Deng YQ, Zhang J, Sakamuru S, Liu B, Huang R, Koetzner CA, Allen CA, Jones SA, Chen H (2017) Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res 27(8):1046\u20131064","journal-title":"Cell Res"},{"key":"1898_CR137","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","volume":"139","author":"H Lee","year":"2017","unstructured":"Lee H, Ren J, Nocadello S, Rice AJ, Ojeda I, Light S, Minasov G, Vargas J, Nagarathnam D, Anderson WF, Johnson ME (2017) Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus. Antivir Res 139:49\u201358","journal-title":"Antivir Res"},{"issue":"3","key":"1898_CR138","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","volume":"39","author":"HJ Lim","year":"2017","unstructured":"Lim HJ, Nguyen TT, Kim NM, Park JS, Jang TS, Kim D (2017) Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Biotechnol Lett 39(3):415\u2013421","journal-title":"Biotechnol Lett"},{"key":"1898_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","volume":"141","author":"JF Chan","year":"2017","unstructured":"Chan JF, Chik KK, Yuan S, Yip CC, Zhu Z, Tee KM, Tsang JO, Chan CC, Poon VK, Lu G, Zhang AJ (2017) Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antivir Res 141:29\u201337","journal-title":"Antivir Res"},{"issue":"4","key":"1898_CR140","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.str.2018.02.005","volume":"26","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang Z, Phoo WW, Loh YR, Li R, Yang HY, Jansson AE, Hill J, Keller TH, Nacro K, Luo D (2018) Structural insights into the inhibition of Zika virus NS2B-NS3 protease by a small-molecule inhibitor. Structure 26(4):555\u2013564","journal-title":"Structure"},{"issue":"12","key":"1898_CR141","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","volume":"3","author":"A Kumar","year":"2018","unstructured":"Kumar A, Liang B, Aarthy M, Singh SK, Garg N, Mysorekar IU, Giri R (2018) Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease. ACS Omega 3(12):18132\u201318141","journal-title":"ACS Omega"},{"key":"1898_CR142","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.antiviral.2018.10.019","volume":"160","author":"MA Coronado","year":"2018","unstructured":"Coronado MA, Eberle RJ, Bleffert N, Feuerstein S, Olivier DS, de Moraes FR, Willbold D, Arni RK (2018) Zika virus NS2B\/NS3 proteinase: a new target for an old drug-Suramin a lead compound for NS2B\/NS3 proteinase inhibition. Antivir Res 160:118\u2013125","journal-title":"Antivir Res"},{"key":"1898_CR143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","volume":"150","author":"Z Li","year":"2018","unstructured":"Li Z, Sakamuru S, Huang R, Brecher M, Koetzner CA, Zhang J, Chen H, Qin CF, Zhang QY, Zhou J, Kramer LD (2018) Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antivir Res 150:217\u2013225","journal-title":"Antivir Res"},{"issue":"2","key":"1898_CR144","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/acs.jcim.9b00933","volume":"60","author":"FR Santos","year":"2019","unstructured":"Santos FR, Nunes DA, Lima WG, Davyt D, Santos LL, Taranto AG, Ferreira MSJ (2019) Identification of Zika virus NS2B-NS3 protease inhibitors by structure-based virtual screening and drug repurposing approaches. J Chem Inf Model 60(2):731\u2013737","journal-title":"J Chem Inf Model"},{"issue":"17","key":"1898_CR145","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1021\/jacs.9b02505","volume":"141","author":"Y Yao","year":"2019","unstructured":"Yao Y, Huo T, Lin YL, Nie S, Wu F, Hua Y, Wu J, Kneubehl AR, Vogt MB, Rico-Hesse R, Song Y (2019) Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease. J Am Chem Soc 141(17):6832\u20136836","journal-title":"J Am Chem Soc"},{"key":"1898_CR146","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","volume":"180","author":"G Rassias","year":"2019","unstructured":"Rassias G, Zogali V, Swarbrick CM, Chan KW, Chan SA, Gwee CP, Wang S, Kaplanai E, Canko A, Kiousis D, Lescar J (2019) Cell-active carbazole derivatives as inhibitors of the Zika virus protease. Eur J Med Chem 180:536\u2013545","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1898_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-65489-w","volume":"10","author":"N Pathak","year":"2020","unstructured":"Pathak N, Kuo YP, Chang TY, Huang CT, Hung HC, Hsu JT, Yu GY, Yang JM (2020) Zika virus NS3 protease pharmacophore anchor model and drug discovery. Sci Rep 10(1):1\u20137","journal-title":"Sci Rep"},{"key":"1898_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.514313","author":"X Cui","year":"2020","unstructured":"Cui X, Zhou R, Huang C, Zhang R, Wang J, Zhang Y, Ding J, Li X, Zhou J, Cen S (2020) Identification of theaflavin-3, 3\u2019-digallate as a novel Zika virus protease inhibitor. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.514313","journal-title":"Front Pharmacol"},{"issue":"4","key":"1898_CR149","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/acsmedchemlett.9b00629","volume":"11","author":"S Pach","year":"2020","unstructured":"Pach S, Sarter TM, Yousef R, Schaller D, Bergemann S, Arkona C, Rademann J, Nitsche C, Wolber G (2020) Catching a moving target: comparative modeling of flaviviral NS2B-NS3 reveals small molecule Zika protease inhibitors. ACS Med Chem Lett 11(4):514\u2013520","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"1898_CR150","doi-asserted-by":"publisher","first-page":"126965","DOI":"10.1016\/j.bmcl.2020.126965","volume":"30","author":"S Voss","year":"2020","unstructured":"Voss S, Nitsche C (2020) Inhibitors of the Zika virus protease NS2B-NS3. Bioorg Med Chem Lett 30(5):126965","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"1898_CR151","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1080\/07391102.2019.1704882","volume":"38","author":"D Akaberi","year":"2020","unstructured":"Akaberi D, Chinthakindi PK, B\u00e5hlstr\u00f6m A, Palanisamy N, Sandstr\u00f6m A, Lundkvist \u00c5, Lennerstrand J (2020) Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease. J Biomol Struct Dyn 38(18):5526\u20135536","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"1898_CR152","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/acsmedchemlett.9b00405","volume":"11","author":"A Coluccia","year":"2020","unstructured":"Coluccia A, Puxeddu M, Nalli M, Wei CK, Wu YH, Mastrangelo E, Elamin T, Tarantino D, Bugert JJ, Schreiner B, Nolte J (2020) Discovery of Zika virus NS2B\/NS3 inhibitors that prevent mice from life-threatening infection and brain damage. ACS Med Chem Lett 11(10):1869\u20131874","journal-title":"ACS Med Chem Lett"},{"key":"1898_CR153","doi-asserted-by":"publisher","first-page":"104719","DOI":"10.1016\/j.bioorg.2021.104719","volume":"109","author":"CS Lima","year":"2021","unstructured":"Lima CS, Mottin M, de Assis LR, Mesquita NC, de Paula Sousa BK, Coimbra LD, Bispo-dos-Santos K, Zorn KM, Guido RV, Ekins S, Marques RE (2021) Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors. Bioorg Chem 109:104719","journal-title":"Bioorg Chem"},{"issue":"5","key":"1898_CR154","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","volume":"64","author":"S Nie","year":"2021","unstructured":"Nie S, Yao Y, Wu F, Wu X, Zhao J, Hua Y, Wu J, Huo T, Lin YL, Kneubehl AR, Vogt MB (2021) Synthesis, structure\u2013activity relationships, and antiviral activity of allosteric inhibitors of Flavivirus NS2B\u2013NS;3 protease. J Med Chem 64(5):2777\u20132800","journal-title":"J Med Chem"},{"key":"1898_CR155","doi-asserted-by":"publisher","first-page":"113767","DOI":"10.1016\/j.ejmech.2021.113767","volume":"225","author":"S Nie","year":"2021","unstructured":"Nie S, Zhao J, Wu X, Yao Y, Wu F, Lin YL, Li X, Kneubehl AR, Vogt MB, Rico-Hesse R, Song Y (2021) Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease. Eur J Med Chem 225:113767","journal-title":"Eur J Med Chem"},{"issue":"14","key":"1898_CR156","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3390\/molecules26144321","volume":"26","author":"T Chong Teoh","year":"2021","unstructured":"Chong Teoh T, Al-Harbi JS, Abdulrahman AY, Rothan HA (2021) Doxycycline interferes with Zika virus serine protease and inhibits virus replication in human skin fibroblasts. Molecules 26(14):4321","journal-title":"Molecules"},{"key":"1898_CR157","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","volume":"143","author":"SA Shiryaev","year":"2017","unstructured":"Shiryaev SA, Farhy C, Pinto A, Huang CT, Simonetti N, Ngono AE, Dewing A, Shresta S, Pinkerton AB, Cieplak P, Strongin AY (2017) Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists. Antivir Res 143:218\u2013229","journal-title":"Antivir Res"},{"issue":"1","key":"1898_CR158","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","volume":"60","author":"C Nitsche","year":"2017","unstructured":"Nitsche C, Zhang L, Weigel LF, Schilz J, Graf D, Bartenschlager R, Hilgenfeld R, Klein CD (2017) Peptide\u2013boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology. J Med Chem 60(1):511\u2013516","journal-title":"J Med Chem"},{"issue":"11","key":"1898_CR159","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41563-018-0194-2","volume":"17","author":"JA Jackman","year":"2018","unstructured":"Jackman JA, Costa VV, Park S, Real AL, Park JH, Cardozo PL, Ferhan AR, Olmo IG, Moreira TP, Bambirra JL, Queiroz VF (2018) Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide. Nat Mater 17(11):971\u2013977","journal-title":"Nat Mater"},{"key":"1898_CR160","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2018.10.006","volume":"160","author":"WW Phoo","year":"2018","unstructured":"Phoo WW, Zhang Z, Wirawan M, Chew EJ, Chew AB, Kouretova J, Steinmetzer T, Luo D (2018) Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors. Antivir Res 160:17\u201324","journal-title":"Antivir Res"},{"issue":"2","key":"1898_CR161","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsmedchemlett.8b00535","volume":"10","author":"C Nitsche","year":"2019","unstructured":"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G (2019) De novo discovery of nonstandard macrocyclic peptides as noncompetitive inhibitors of the Zika virus NS2B-NS3 protease. ACS Med Chem Lett 10(2):168\u2013174","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"1898_CR162","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10989-019-09808-4","volume":"25","author":"AY Abdulrahman","year":"2019","unstructured":"Abdulrahman AY, Khazali AS, Teoh TC, Rothan HA, Yusof R (2019) Novel peptides inhibit zika NS2B-NS3 serine protease and virus replication in human hepatic cell line. Int J Pept Res Ther 25(4):1659\u20131668","journal-title":"Int J Pept Res Ther"},{"issue":"3","key":"1898_CR163","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5808\/GI.2016.14.3.104","volume":"14","author":"M Sahoo","year":"2016","unstructured":"Sahoo M, Lingaraja Jena SD, Kumar S (2016) Virtual screening for potential inhibitors of NS3 protein of Zika virus. Genom Inform 14(3):104","journal-title":"Genom Inform"},{"key":"1898_CR164","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jmgm.2016.08.011","volume":"69","author":"KG Byler","year":"2016","unstructured":"Byler KG, Ogungbe IV, Setzer WN (2016) In-silico screening for anti-Zika virus phytochemicals. J Mol Graph Model 69:78\u201391","journal-title":"J Mol Graph Model"},{"issue":"5","key":"1898_CR165","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.17582\/journal.pjz\/2018.50.5.1709.1715","volume":"50","author":"M Fatima","year":"2018","unstructured":"Fatima M, Khan MS, Rashid H, Mehmood A, Kanwal S, Rasheed MA, Jamil F (2018) Structure based virtual screening and molecular docking studies for identification of allosteric inhibitors against Zika virus protease NS2B-NS3. Pak J Zool 50(5):1709\u20131715","journal-title":"Pak J Zool"},{"issue":"1","key":"1898_CR166","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12010-018-2814-3","volume":"187","author":"K Rohini","year":"2019","unstructured":"Rohini K, Agarwal P, Preethi B, Shanthi V, Ramanathan K (2019) Exploring the lead compounds for Zika virus NS2B-NS3 protein: an e-pharmacophore-based approach. Appl Biochem Biotechnol 187(1):194\u2013210","journal-title":"Appl Biochem Biotechnol"},{"issue":"7","key":"1898_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-019-4076-6","volume":"25","author":"LR Bowen","year":"2019","unstructured":"Bowen LR, Li DJ, Nola DT, Anderson MO, Heying M, Groves AT, Eagon S (2019) Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening. J Mol Model 25(7):1","journal-title":"J Mol Model"},{"key":"1898_CR168","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3947245","author":"H Choudhry","year":"2019","unstructured":"Choudhry H, Alzahrani FA, Hassan MA, Alghamdi A, Abdulaal WH, Bakhrebah MA, Zamzami MA, Helmi N, Bokhari FF, Zeyadi M, Baothman OA (2019) Zika virus targeting by screening inhibitors against NS2B\/NS3 protease. Biomed Res Int. https:\/\/doi.org\/10.1155\/2019\/3947245","journal-title":"Biomed Res Int"},{"key":"1898_CR169","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1956592","author":"GS Thirumoorthy","year":"2021","unstructured":"Thirumoorthy GS, Tarachand SP, Nagella P, Veerappa Lakshmaiah V (2021) Identification of potential ZIKV NS2B-NS3 protease inhibitors from Andrographis paniculata: an in-silico approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1956592","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"1898_CR170","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/microorganisms9030545","volume":"9","author":"HJ Shin","year":"2021","unstructured":"Shin HJ, Kim MH, Lee JY, Hwang I, Yoon GY, Kim HS, Kwon YC, Ahn DG, Kim KD, Kim BT, Kim SJ (2021) Structure-based virtual screening: identification of a novel NS2B-NS3 protease inhibitor with potent antiviral activity against Zika and Dengue viruses. Microorganisms 9(3):545","journal-title":"Microorganisms"},{"issue":"1","key":"1898_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14762","volume":"8","author":"B Zhao","year":"2017","unstructured":"Zhao B, Yi G, Du F, Chuang YC, Vaughan RC, Sankaran B, Kao CC, Li P (2017) Structure and function of the Zika virus full-length NS5 protein. Nat Commun 8(1):1\u20139","journal-title":"Nat Commun"},{"issue":"5","key":"1898_CR172","doi-asserted-by":"publisher","first-page":"e0004695","DOI":"10.1371\/journal.pntd.0004695","volume":"10","author":"J Zmurko","year":"2016","unstructured":"Zmurko J, Marques RE, Schols D, Verbeken E, Kaptein SJ, Neyts J (2016) The viral polymerase inhibitor 7-deaza-2\u2019-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model. PLoS Negl Trop Dis 10(5):e0004695","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1898_CR173","first-page":"727","volume":"72","author":"HT Xu","year":"2017","unstructured":"Xu HT, Hassounah SA, Colby-Germinario SP, Oliveira M, Fogarty C, Quan Y, Han Y, Golubkov O, Ibanescu I, Brenner B, Stranix BR (2017) Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors. J Antimicrob Chemother 72(3):727\u2013734","journal-title":"J Antimicrob Chemother"},{"key":"1898_CR174","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","volume":"137","author":"KM Bullard-Feibelman","year":"2017","unstructured":"Bullard-Feibelman KM, Govero J, Zhu Z, Salazar V, Veselinovic M, Diamond MS, Geiss BJ (2017) The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antivir Res 137:134\u2013140","journal-title":"Antivir Res"},{"issue":"4","key":"1898_CR175","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbrc.2017.10.016","volume":"493","author":"C Wang","year":"2017","unstructured":"Wang C, Yang SN, Smith K, Forwood JK, Jans DA (2017) Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection. Biochem Biophys Res Commun 493(4):1555\u20131559","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1898_CR176","doi-asserted-by":"publisher","first-page":"e01967","DOI":"10.1128\/AAC.01967-16","volume":"61","author":"G Lu","year":"2017","unstructured":"Lu G, Bluemling GR, Collop P, Hager M, Kuiper D, Gurale BP, Painter GR, De La Rosa A, Kolykhalov AA (2017) Analysis of ribonucleotide 5\u2032-triphosphate analogs as potential inhibitors of Zika virus RNA-dependent RNA polymerase by using nonradioactive polymerase assays. Antimicrob Agents Chemother 61(3):e01967-e2016","journal-title":"Antimicrob Agents Chemother"},{"key":"1898_CR177","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","volume":"149","author":"X Tong","year":"2018","unstructured":"Tong X, Smith J, Bukreyeva N, Koma T, Manning JT, Kalkeri R, Kwong AD, Paessler S (2018) Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens. Antivir Res 149:34\u201340","journal-title":"Antivir Res"},{"issue":"1","key":"1898_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-018-0034-1","volume":"4","author":"S Yang","year":"2018","unstructured":"Yang S, Xu M, Lee EM, Gorshkov K, Shiryaev SA, He S, Sun W, Cheng YS, Hu X, Tharappel AM, Lu B (2018) Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry. Cell Discov 4(1):1\u20134","journal-title":"Cell Discov"},{"key":"1898_CR179","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2017.12.016","volume":"151","author":"A Pattnaik","year":"2018","unstructured":"Pattnaik A, Palermo N, Sahoo BR, Yuan Z, Hu D, Annamalai AS, Vu HL, Correas I, Prathipati PK, Destache CJ, Li Q (2018) Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening. Antivir Res 151:78\u201386","journal-title":"Antivir Res"},{"issue":"4","key":"1898_CR180","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ijantimicag.2019.07.010","volume":"54","author":"Y Lin","year":"2019","unstructured":"Lin Y, Zhang H, Song W, Si S, Han Y, Jiang J (2019) Identification and characterization of Zika virus NS5 RNA-dependent RNA polymerase inhibitors. Int J Antimicrob Agents 54(4):502\u2013506","journal-title":"Int J Antimicrob Agents"},{"issue":"21","key":"1898_CR181","doi-asserted-by":"publisher","first-page":"e00794","DOI":"10.1128\/JVI.00794-20","volume":"94","author":"A Gharbi-Ayachi","year":"2020","unstructured":"Gharbi-Ayachi A, Santhanakrishnan S, Wong YH, Chan KW, Tan ST, Bates RW, Vasudevan SG, El Sahili A, Lescar J (2020) Non-nucleoside inhibitors of Zika virus RNA-dependent RNA polymerase. J Virol 94(21):e00794-e820","journal-title":"J Virol"},{"issue":"1","key":"1898_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01663-1","volume":"18","author":"J Yuan","year":"2020","unstructured":"Yuan J, Yu J, Huang Y, He Z, Luo J, Wu Y, Zheng Y, Wu J, Zhu X, Wang H, Li M (2020) Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus. BMC Med 18(1):1\u20136","journal-title":"BMC Med"},{"key":"1898_CR183","doi-asserted-by":"publisher","first-page":"105117","DOI":"10.1016\/j.antiviral.2021.105117","volume":"192","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Z, Pan P, Lao Z, Xu J, Li Z, Zhan S, Liu X, Wu Y, Wang W, Li G (2021) Cinnamic acid inhibits Zika virus by inhibiting RdRp activity. Antivir Res 192:105117","journal-title":"Antivir Res"},{"key":"1898_CR184","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00894-21","author":"Y S\u00e1ez-\u00c1lvarez","year":"2021","unstructured":"S\u00e1ez-\u00c1lvarez Y, Jim\u00e9nez de Oya N, Del \u00c1guila C, Saiz JC, Arias A, Agudo R, Mart\u00edn-Acebes MA (2021) Novel non-nucleoside inhibitors of Zika virus polymerase identified through the screening of an open library of anti-kynetoplastid compounds. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00894-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"50","key":"1898_CR185","doi-asserted-by":"publisher","first-page":"16212","DOI":"10.1021\/jacs.6b10399","volume":"138","author":"P Stephen","year":"2016","unstructured":"Stephen P, Baz M, Boivin G, Lin SX (2016) Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors. J Am Chem Soc 138(50):16212\u201316215","journal-title":"J Am Chem Soc"},{"issue":"7","key":"1898_CR186","first-page":"2091","volume":"162","author":"K Hercik","year":"2017","unstructured":"Hercik K, Brynda J, Nencka R, Boura E (2017) Structural basis of Zika virus methyltransferase inhibition by sinefungin. Adv Virol 162(7):2091\u20132096","journal-title":"Adv Virol"},{"key":"1898_CR187","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ejmech.2018.09.056","volume":"161","author":"J Hernandez","year":"2019","unstructured":"Hernandez J, Hoffer L, Coutard B, Querat G, Roche P, Morelli X, Decroly E, Barral K (2019) Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors. Eur J Med Chem 161:323\u2013333","journal-title":"Eur J Med Chem"},{"issue":"4","key":"1898_CR188","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cmdc.201900533","volume":"15","author":"S Spizzichino","year":"2020","unstructured":"Spizzichino S, Mattedi G, Lauder K, Valle C, Aouadi W, Canard B, Decroly E, Kaptein SJ, Neyts J, Graham C, Sule Z (2020) Design, synthesis and discovery of N, N\u2019-carbazoyl-aryl-urea Inhibitors of Zika NS5 methyltransferase and virus replication. ChemMedChem 15(4):385","journal-title":"ChemMedChem"},{"key":"1898_CR189","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fcimb.2021.665379","volume":"11","author":"W Song","year":"2021","unstructured":"Song W, Zhang H, Zhang Y, Chen Y, Lin Y, Han Y, Jiang J (2021) Identification and characterization of Zika Virus NS5 methyltransferase inhibitors. Front Cell Infect Microbiol 11:267","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"1898_CR190","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/jmv.24678","volume":"88","author":"AA Elfiky","year":"2016","unstructured":"Elfiky AA (2016) Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials. J Med Virol 88(12):2044\u20132051","journal-title":"J Med Virol"},{"key":"1898_CR191","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.compbiolchem.2017.10.007","volume":"71","author":"A Singh","year":"2017","unstructured":"Singh A, Jana NK (2017) Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening. Comput Biol Chem 71:144\u2013151","journal-title":"Comput Biol Chem"},{"issue":"5","key":"1898_CR192","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/07391102.2017.1313175","volume":"36","author":"P Ramharack","year":"2018","unstructured":"Ramharack P, Soliman ME (2018) Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery. J Biomol Struct Dyn 36(5):1118\u20131133","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"1898_CR193","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmv.25573","volume":"92","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Novel guanosine derivatives against Zika virus polymerase in silico. J Med Virol 92(1):11\u201316","journal-title":"J Med Virol"},{"issue":"12","key":"1898_CR194","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jsps.2020.10.005","volume":"28","author":"R Ali","year":"2020","unstructured":"Ali R, Badshah SL, Faheem M, Abbasi SW, Ullah R, Bari A, Jamal SB, Mahmood HM, Haider A, Haider S (2020) Identification of potential inhibitors of Zika virus NS5 RNA-dependent RNA polymerase through virtual screening and molecular dynamic simulations. Saudi Pharm J 28(12):1580\u20131591","journal-title":"Saudi Pharm J"},{"issue":"4","key":"1898_CR195","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbrc.2016.11.098","volume":"492","author":"C Zhang","year":"2017","unstructured":"Zhang C, Feng T, Cheng J, Li Y, Yin X, Zeng W, Jin X, Li Y, Guo F, Jin T (2017) Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design. Biochem Biophys Res Commun 492(4):624\u2013630","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1898_CR196","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1021\/acs.jcim.9b00809","volume":"60","author":"FR Santos","year":"2020","unstructured":"Santos FR, Lima WG, Maia EH, Assis LC, Davyt D, Taranto AG, Ferreira JM (2020) Identification of a potential Zika virus inhibitor targeting NS5 methyltransferase using virtual screening and molecular dynamics simulations. J Chem Inf Model 60(2):562\u2013568","journal-title":"J Chem Inf Model"},{"issue":"7","key":"1898_CR197","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/07391102.2020.1747545","volume":"39","author":"S Bharadwaj","year":"2021","unstructured":"Bharadwaj S, Rao AK, Dwivedi VD, Mishra SK, Yadava U (2021) Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM\/MM affinity estimation. J Biomol Struct Dyn 39(7):2338\u20132351","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"1898_CR198","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41579-021-00538-3","volume":"19","author":"K Kingwell","year":"2021","unstructured":"Kingwell K (2021) Pan-serotype antiviral for dengue infection. Nat Rev Microbiol 19(4):221","journal-title":"Nat Rev Microbiol"},{"key":"1898_CR199","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.virol.2020.09.004","volume":"552","author":"SL Scroggs","year":"2021","unstructured":"Scroggs SL, Gass JT, Chinnasamy R, Widen SG, Azar SR, Rossi SL, Arterburn JB, Vasilakis N, Hanley KA (2021) Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness. Virology 552:94\u2013106","journal-title":"Virology"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-022-01898-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T20:25:24Z","timestamp":1726950324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-022-01898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":199,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1007\/s11262-022-01898-5","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the study does not involve any human participants and\/or Animals, consent from the participants is not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that the study does not involve any human participants and\/or Animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals statement"}}]}}